Sfoglia per AUTORE
CONTE B
Collezione ASL Città di Torino

  

Items : 4

Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial. in ESMO open / ESMO Open. 2024 Aug;9(8):103650. doi: 10.1016/j.esmoop.2024.103650. Epub 2024 Aug 8.

2024
ASL Città di Torino

Boni L; Lambertini M; Puglisi F; Colantuoni G; Fregatti P; Fozza A; Molinelli C; Poletti P; Correale P; Urracci Y; Garrone O; Alicicco MG; Fabi A; Gasparro S; Magnolfi E; Nisticò C; Turletti A; Bisagni G; Rimanti A; De Laurentiis M; Gravina A; Giuliano M; Arpino G; Perachino M; Conte B; Nardin S; Del Mastro L; Poggio F; Blondeaux E; et alii...

SNP of Aromatase Predict Long-term Survival and Aromatase Inhibitor Toxicity in Patients with Early Breast Cancer: A Biomarker Analysis of the GIM4 and GIM5 Trials. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2023 Dec 15;29(24):5217-5226. doi: 10.1158/1078-0432.CCR-23-1568.

2023
AOU Città della Salute di Torino
ASL Città di Torino
AOU Alessandria

Prat A; Cardinali B; Piccioli P; Serra M; Lastraioli S; Bighin C; Poggio F; Lambertini M; Del Mastro L; Frassoldati A; Porpiglia M; Fabi A; Generali D; Scognamiglio G; Rossi M; Brasó-Maristany F; Puglisi F; Mansutti M; De Angioletti M; Notaro R; Turletti A; Lunardi G; Pazzola A; Ponzone R; Montemurro F; Schettini F; De Placido S; Tamberi S; Gori S; et alii...

Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial. in International journal of cancer / Int J Cancer. 2020 Jul 1;147(1):160-169. doi: 10.1002/ijc.32789. Epub 2019 Dec 4.

2020
ASL Città di Torino
AO Cuneo
AOU Città della Salute di Torino

Del Mastro L; Ceppi M; Montemurro F; Puglisi F; Garrone O; Fabi A; Bisagni G; Durando A; Turletti A; Urracci Y; Cognetti F; De Laurentiis M; Giuliano M; Bighin C; de Azambuja E; Conte B; Poggio F; Bruzzone M; Lambertini M;

Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM). in Cancers / Cancers (Basel). 2019 Aug 8;11(8):1137. doi: 10.3390/cancers11081137.

2019
ASL Città di Torino

Dieci MV; Del Mastro L; Cinquini M; Montemurro F; Biganzoli L; Cortesi L; Zambelli A; Criscitiello C; Levaggi A; Conte B; Calabrese M; Fiorentino A; Marchiò C; Tinterri C; Fittipaldo VA; Pappagallo G; Gori S;